The US investment bank says the phase 3 results in ovarian cancer change its view of the drug candidate and still point to ...
AbbVie will test lutikizumab together with ABBV-295, the amylin-based obesity drug it licensed from Danish biotech Gubra, ...
Danish allergy specialist ALK says a phase 3 trial in China has confirmed the safety and efficacy of its tablet Acarizax in patients with house dust mite allergy. The tablet is not yet approved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results